Sign inJoin waitlistJoin the waitlist

Sindhu Devarashetty

Assistant Professor - Clinical of Internal Medicine, Division of Hematology and Oncology, Feist-Weiller Cancer Center · LSU Health Sciences Center

Credentials: · · · · · · ·

History

LSU Health Sciences Center
Present

Hematology and Medical Oncology
LSU Health Sciences Center
2020–2023
Internal Medicine
Indiana University School of Medicine
2017–2020
Doctor of Medicine
2010–2014

Research

Not Your Typical Adenocarcinoma: A Case of Mesonephric Adenocarcinoma of the Cervix With Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation
Case report · Cureus · 2022 · First of 3 authors · 9 citations
Vancomycin Induced Thrombocytopenia - Protracted Course in a Hemodialysis Patient
Case report · Case Reports in Oncology · 2019 · 6 citations
COVID-19 infection unmasking glucose-6-phosphate dehydrogenase deficiency
QJM · 2022 · First of 4 authors · 2 citations

Poornima Ramadas
2 papers
Richard Mansour
2 papers
SM
Samip Master
2 papers
AP
Alok Pant
1 paper
KL
Kimberly Leblanc
1 paper · 1 as a fellow
Nisha Ajit
1 paper · 1 as a fellow
Pramod Ponna
1 paper
SC
Suma Chennapragada
1 paper · 1 as a fellow
Udhayvir Grewal
1 paper · 1 as a fellow

Clinical trials

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033